Episode

Episode 3: Limitations of AI in Life Sciences

Podcast: From Models to Medicine
Published: Apr 1, 2026
Duration seconds: 2218
Processing state: not_requested
Canonical source: https://podcasters.spotify.com/pod/show/kami-think-tank/episodes/Episode-3-Limitations-of-AI-in-Life-Sciences-e3h761h
Audio: https://anchor.fm/s/110164688/podcast/play/117724657/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-2-31%2F4d35fac8-ed6e-503c-575f-15ed760634d9.mp3
JSON: /v1/public/podcasts/from-models-to-medicine-7769799/episodes/episode-3-limitations-of-ai-in-life-sciences
Markdown: /podcast/from-models-to-medicine-7769799/episode-3-limitations-of-ai-in-life-sciences.md

Actions

POST https://stenobird.com/v1/public/podcasts/from-models-to-medicine-7769799/episodes/episode-3-limitations-of-ai-in-life-sciences/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/from-models-to-medicine-7769799/episode-3-limitations-of-ai-in-life-sciences.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of From Models to Medicine, we sit down with Rachel Thomas to discuss the growing gap between AI hype and scientific reality in the life sciences. The conversation highlights the hidden costs of poor data quality and the necessity of domain expertise, featuring deep dives into real-world AI missteps, from a flawed enzyme classification paper to an app's mishandling of long-COVID data.